TALSOL CORP. – Trademark Portfolio

Entity Type: 03

TALSOL CORP. owns a portfolio of 24 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as MAR-HYDE, ONE-STEP, and SINGLE STAGE. Of these, 3 are registered. The portfolio spans 3 Nice Classification classes, led by Class 2 (Paints) and Class 1 (Chemicals). Headquartered in CINCINNATI, OH.

2017 E. KEMPER ROAD

CINCINNATI, OH

24 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

TALSOL CORP.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

2
Paints (11 filings)

Paints, varnishes, lacquers; preservatives against rust and against deterioration of wood

1
Chemicals (8 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

3
Cosmetics & Cleaning (6 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Frequently Asked Questions

How many trademarks does TALSOL CORP. have?

TALSOL CORP. has 24 U.S. trademarks filed with the USPTO. Of these, 3 registered, 3 abandoned, 18 cancelled.

What trademark classes does TALSOL CORP. file in?

TALSOL CORP. files trademarks across 3 Nice Classification classes. The most active classes are Class 2 (Paints), Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning). Class 2 covers paints, varnishes, lacquers; preservatives against rust and against deterioration of wood.

What are TALSOL CORP.'s most well-known trademarks?

TALSOL CORP.'s registered trademark portfolio includes well-known marks such as MAR-HYDE, ONE-STEP, and SINGLE STAGE. These are among 3 currently registered trademarks in the portfolio.

What is TALSOL CORP.'s trademark registration success rate?

TALSOL CORP. has a 13% trademark registration rate, with 3 out of 24 resolved applications resulting in successful registration. Currently, 0 applications are pending review.